Advertisement

Index by author

July 01, 2012; Volume 342,Issue 1

  1. Handler, Jeffrey A.

    1. MLR-1023 Is a Potent and Selective Allosteric Activator of Lyn Kinase In Vitro That Improves Glucose Tolerance In Vivo
      Michael S. Saporito, Alexander R. Ochman, Christopher A. Lipinski, Jeffrey A. Handler and Andrew G. Reaume
      Journal of Pharmacology and Experimental Therapeutics July 2012, 342 (1) 15-22; DOI: https://doi.org/10.1124/jpet.112.192096
    2. The Lyn Kinase Activator MLR-1023 Is a Novel Insulin Receptor Potentiator that Elicits a Rapid-Onset and Durable Improvement in Glucose Homeostasis in Animal Models of Type 2 Diabetes
      Alexander R. Ochman, Christopher A. Lipinski, Jeffrey A. Handler, Andrew G. Reaume and Michael S. Saporito
      Journal of Pharmacology and Experimental Therapeutics July 2012, 342 (1) 23-32; DOI: https://doi.org/10.1124/jpet.112.192187

  2. He, Xiaoqing

    1. Resveratrol Inhibits Paraquat-Induced Oxidative Stress and Fibrogenic Response by Activating the Nuclear Factor Erythroid 2-Related Factor 2 Pathway
      Xiaoqing He, Liping Wang, Grazyna Szklarz, Yongyi Bi and Qiang Ma
      Journal of Pharmacology and Experimental Therapeutics July 2012, 342 (1) 81-90; DOI: https://doi.org/10.1124/jpet.112.194142

  3. Hendrickx, Herman

    1. Pharmacology of JNJ-37822681, a Specific and Fast-Dissociating D2 Antagonist for the Treatment of Schizophrenia
      Xavier Langlois, Anton Megens, Hilde Lavreysen, John Atack, Miroslav Cik, Paula te Riele, Luc Peeters, Ria Wouters, Jef Vermeire, Herman Hendrickx, Gregor Macdonald and Marcel De Bruyn
      Journal of Pharmacology and Experimental Therapeutics July 2012, 342 (1) 91-105; DOI: https://doi.org/10.1124/jpet.111.190702

  4. Henry, Scott P.

    1. Unique O-Methoxyethyl Ribose-DNA Chimeric Oligonucleotide Induces an Atypical Melanoma Differentiation-Associated Gene 5-Dependent Induction of Type I Interferon Response
      Sebastien A. Burel, Todd Machemer, Frank L. Ragone, Hiroki Kato, Patrick Cauntay, Sarah Greenlee, Aneeza Salim, William A. Gaarde, Gene Hung, Raechel Peralta, Susan M. Freier and Scott P. Henry
      Journal of Pharmacology and Experimental Therapeutics July 2012, 342 (1) 150-162; DOI: https://doi.org/10.1124/jpet.112.193789

  5. Hoyano, Yuji

    1. Effects of Ritobegron (KUC-7483), a Novel Selective β3-Adrenoceptor Agonist, on Bladder Function in Cynomolgus Monkey
      Itaru Maruyama, Satoshi Tatemichi, Yoshiaki Goi, Kazuyasu Maruyama, Yuji Hoyano, Yoshinobu Yamazaki and Hiroshi Kusama
      Journal of Pharmacology and Experimental Therapeutics July 2012, 342 (1) 163-168; DOI: https://doi.org/10.1124/jpet.112.191783

  6. Huang, Lv-Zhen

    1. Polyethylene Glycol-Modified Pigment Epithelial-Derived Factor: New Prospects for Treatment of Retinal Neovascularization
      Yu-Jing Bai, Lv-Zhen Huang, Xiao-Lei Xu, Wei Du, Ai-Yi Zhou, Wen-Zhen Yu and Xiao-Xin Li
      Journal of Pharmacology and Experimental Therapeutics July 2012, 342 (1) 131-139; DOI: https://doi.org/10.1124/jpet.112.192575

  7. Hung, Gene

    1. Unique O-Methoxyethyl Ribose-DNA Chimeric Oligonucleotide Induces an Atypical Melanoma Differentiation-Associated Gene 5-Dependent Induction of Type I Interferon Response
      Sebastien A. Burel, Todd Machemer, Frank L. Ragone, Hiroki Kato, Patrick Cauntay, Sarah Greenlee, Aneeza Salim, William A. Gaarde, Gene Hung, Raechel Peralta, Susan M. Freier and Scott P. Henry
      Journal of Pharmacology and Experimental Therapeutics July 2012, 342 (1) 150-162; DOI: https://doi.org/10.1124/jpet.112.193789
Back to top

In this issue

Advertisement